How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Randox Laboratories Ltd. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
115 clearance records and 79 recall records in the covered releases, across 1 source company names and 82 product codes. Dated history runs from Oct 15, 1992 to Jun 7, 2024.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Randox Liquid Assayed Specific Protein Control - Level 2 (SP Control 2), Cat. no. PS2683Z-2279-2018 · JJY | Randox Laboratories Ltd. | Recall | Jun 13, 2018FDA classification date |
| Randox Liquid Assayed Specific Protein Control - Level 3 (SP Control 3), Cat. no. PS2684Z-2280-2018 · JJY | Randox Laboratories Ltd. | Recall | Jun 13, 2018FDA classification date |
| Lipase, Catalog number: LI3837; GTIN: 05055273204230 and Catalog number: LI8361; GTIN: 05055273214284 Product Usage: For Professional Use for th…Z-1631-2018 · CDT | Randox Laboratories Ltd. | Recall | May 4, 2018FDA record creation date |
| Rx series HbA1c REF/Catalog Number HA3830, GTIN 05055273203561, IVD; -- RANDOX LABORATORIES LTD. , This product is suitable for use on RX series…Z-0285-2018 · LCP | Randox Laboratories Ltd. | Recall | Dec 22, 2017FDA record creation date |
| Randox RX Daytona Plus Magnesium (MG)K162200 · JGJ | Randox Laboratories, Ltd. | 510(k) | Apr 28, 2017FDA decision date |
| Randox Lipase (Colorimetric) Product Usage: A lipase test system is a device intended to measure the activity of the enzyme lipase in serum and …Z-0123-2017 · CDT | Randox Laboratories Ltd. | Recall | Oct 18, 2016FDA classification date |
| IgE Calibrator SeriesZ-0050-2017 · DGC | Randox Laboratories Ltd. | Recall | Oct 6, 2016FDA classification date |
| Liquid CO2-2 (LCO2-2)K152085 · KHS | Randox Laboratories, Ltd. | 510(k) | Feb 24, 2016FDA decision date |
| Direct HDL Cholesterol (HDL)K153435 · LBS | Randox Laboratories, Ltd. | 510(k) | Jan 8, 2016FDA decision date |
| CholesterolK150654 · CHH | Randox Laboratories, Ltd. | 510(k) | Sep 29, 2015FDA decision date |
| RX DAYTONA PLUS CHEMISTRY ANALYZER; RX DAYTONA PLUS ASPARTATE AMINOTRANSFERASE (AST) REAGENTK131554 · JJE | Randox Laboratories, Ltd. | 510(k) | Jan 9, 2014FDA decision date |
| RANDOX LIQUID CK-MB, RANDOX CK-MB CALIBRATORK123977 · CGS | Randox Laboratories, Ltd. | 510(k) | Nov 21, 2013FDA decision date |
| RANDOX CSF CONTROLS LEVELS 2 AND 3K132156 · JJY | Randox Laboratories, Ltd. | 510(k) | Oct 23, 2013FDA decision date |
| BENZODIAZEPINE CALIBRATOR SET, BENZODIAZEPINE CONTROL LEVEL 1, AND BENZODIAZEPINE CONTROL LEVEL 2K132090 · DLJ | Randox Laboratories, Ltd. | 510(k) | Aug 8, 2013FDA decision date |
| HBA1C CONTROL, LEVEL 1 AND LEVEL 2K131999 · JJX | Randox Laboratories, Ltd. | 510(k) | Jul 26, 2013FDA decision date |
| ALDOLASE CONTROLS LEVEL 2, AND ALDOLASE CONTROL LEVEL 3K131776 · JJX | Randox Laboratories, Ltd. | 510(k) | Jul 18, 2013FDA decision date |
| RANDOX IMMUNOASSAY SPECIALITY CONTROL (II), LEVEL 1, LEVEL 2 AND LEVEL 3K121603 · JJY | Randox Laboratories, Ltd. | 510(k) | Nov 20, 2012FDA decision date |
| RANDOX MATERNAL CONTROL, LEVELS 1, 2 AND 3K113720 · JJY | Randox Laboratories, Ltd. | 510(k) | Sep 20, 2012FDA decision date |
| RANDOX MICROALBUMIN CONTROL LEVEL 1 AND CONTROL LEVEL 2 (LIQUID)K121746 · JJX | Randox Laboratories, Ltd. | 510(k) | Jul 11, 2012FDA decision date |
| RANDOX CYSTATIN C CONTROL LEVEL 2 RANDOX CYSTATIN C CONTROL LEVEL 3K121588 · JJX | Randox Laboratories, Ltd. | 510(k) | Jun 20, 2012FDA decision date |
| RANDOX COCAINE METABOLITEK113751 · DIO | Randox Laboratories, Ltd. | 510(k) | May 8, 2012FDA decision date |
| RANDOX LIQUID IMMUNOASSAY PREMIUM CONTROLS, LEVEL 1, LEVEL2, LEVEL 3 AND TRI LEVELK112337 · JJY | Randox Laboratories, Ltd. | 510(k) | Dec 1, 2011FDA decision date |
| RANDOX DIGOXIN ASSAYK102346 · KXT | Randox Laboratories, Ltd. | 510(k) | Oct 14, 2011FDA decision date |
| RANDOX LIQUID URINE CONTROL LEVELS 2 AND 3K110904 · JJY | Randox Laboratories, Ltd. | 510(k) | Sep 30, 2011FDA decision date |
| RANDOX BARITURATES ASSAYK092268 · DIS | Randox Laboratories, Ltd. | 510(k) | May 25, 2011FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.